Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
C75 treatment of rodent adipocytes and hepatocytes and human breast cancer cells increases fatty acid oxidation and ATP levels by increasing CPT-1 activity
InChiKey: SRVSDBHUBFLSFE-XERRXZQWSA-N
ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1
Exhibits no detectable binding of VHL
Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
Valacyclovir - CAS# 124832-26-4 a-Naloxol D5 Hydrochloride C75 treatment of rodent adipocytesValacyclovir, also known as valacyclovir, is an antiviral drug used in the management of herpes simplex, herpes zoster (shingles), and herpes B. It is a prodrug, being converted in vivo to aciclovir. Valaciclovir has been available as a generic drug in the U. S. since November 25, 2009. Valaciclovir is a prodrug, an esterified version of aciclovir that has greater oral bioavailability (about 55%) than aciclovir (1020%). It is converted by esterases to